Nutex Health Inc.
NUTX
$187.60
$1.760.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -13.62% | 2.22% | -41.12% | 239.87% | 220.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.62% | 2.22% | -41.12% | 239.87% | 220.69% |
| Cost of Revenue | -43.63% | 34.98% | -10.71% | 107.91% | 132.33% |
| Gross Profit | 12.62% | -21.23% | -62.08% | 494.61% | 380.45% |
| SG&A Expenses | -78.56% | -72.22% | -389.15% | 107.24% | 761.53% |
| Depreciation & Amortization | 1.31% | 7.86% | -1.78% | 0.62% | 15.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.66% | 3.12% | -97.38% | 100.03% | 228.03% |
| Operating Income | 261.41% | 0.75% | 29.44% | 1,192.30% | 181.36% |
| Income Before Tax | 393.36% | 7.50% | -76.17% | 4,903.84% | 507.89% |
| Income Tax Expenses | 173.70% | -32.40% | 1.46% | 491.93% | 748.77% |
| Earnings from Continuing Operations | 496.61% | 23.53% | -83.31% | 1,451.00% | 436.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.95% | 46.07% | 87.40% | -2,448.61% | -902.99% |
| Net Income | 472.05% | 120.61% | -80.79% | 730.80% | -4,761.81% |
| EBIT | 261.41% | 0.75% | 29.44% | 1,192.30% | 181.36% |
| EBITDA | 226.34% | 1.17% | 28.06% | 798.87% | 135.88% |
| EPS Basic | 424.62% | 78.86% | -85.83% | 580.08% | -3,932.79% |
| Normalized Basic EPS | 296.01% | 73.30% | 107.74% | 1,025.07% | -587.07% |
| EPS Diluted | 417.75% | 95.90% | -86.16% | 550.35% | -3,932.79% |
| Normalized Diluted EPS | 291.81% | 92.09% | 121.00% | 963.70% | -587.07% |
| Average Basic Shares Outstanding | 14.61% | 23.34% | 35.59% | 31.40% | 20.63% |
| Average Diluted Shares Outstanding | 17.12% | 11.28% | 27.45% | 40.74% | 20.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |